Clomiphene or tamoxifen for idiopathic oligo/asthenospermia
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Oligo-astheno-teratospermia (sperm of low concentration, reduced motility and increased abnormal morphology) of unknown cause is common and the need for treatment is felt by patients and doctors alike. As a result, a variety of empirical, non-specific treatments have been used in an attempt to improve semen characteristics and fertility.The administration of anti-oestrogens is a common treatment because anti oestrogens interfere with the normal negative feedback of sex steroids at hypothalamic and pituitary levels in order to increase endogenous gonadotropin-releasing hormone secretion from the hypothalamus and FSH and LH secretion directly from the pituitary. In turn, FSH and LH stimulate Leydig cells in the testes, and this has been claimed to lead to increased local testosterone production, thereby boosting spermatogenesis with a possible improvement in fertility. There may also be a direct effect of anti-oestrogens on testicular spermatogenesis or steroidogenesis. This review considers the available evidence of the effect of both Clomiphene citrate and tamoxifen, both of which have a predominant anti-oestrogenic effect, for idiopathic oligo and/or asthenospermia. OBJECTIVES: The objective was to assess the effects of treating subfertile men with anti-oestrogens (clomiphene or tamoxifen) on pregnancy rates among couples where subfertility has been attributed to idiopathic oligo- and/or asthenospermia. SEARCH STRATEGY: The Cochrane Subfertility Review Group specialised register of controlled trials was searched". SELECTION CRITERIA: Randomised trials of anti-oestrogen therapy for 3 months or more compared to placebo or no placebo for subfertile males among couples where subfertility is attributed to male factor. DATA COLLECTION AND ANALYSIS: Data were extracted independently by two reviewers. Any differences were resolved with a third reviewer. MAIN RESULTS: Ten studies involving 738 men were included. Five of the trials did not specify method of randomisation. Anti-oestrogens had a positive effect on endocrinal outcomes, such as serum testosterone levels. In trials with secure randomisation there was no difference in the pregnancy rate between the anti-oestrogen groups and the control groups (odds ratio 1.26, 95% confidence interval 0.99 to 1.56). The overall pregnancy rate for these five trials was 15.4% compared to the spontaneous rate of 12.5% in the control groups. These odds increased to 1.56 (95% confidence interval 0.99 to 2.19) when all 10 trials were included, but this result is likely to be artificially inflated. AUTHORS' CONCLUSIONS: Anti-oestrogens appear to have a beneficial effect on endocrinal outcomes, but there is not enough evidence to evaluate the use of anti-oestrogens for increasing the fertility of males with idiopathic oligo-asthenospermia.[This abstract was prepared centrally.].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Population study of causes, treatment, and outcome of infertility.
Hull, M. G., Glazener, C. M., Kelly, N. J., Conway, D. I., Foster, P. A., Hinton, R. A., Coulson, C., Lambert, P. A., Watt, E. M., & Desai, K. M. (1985) · BMJ · doi:10.1136/bmj.291.6510.1693 · Cited by 1,141
Research works printed but not linked: 45
- Ainmelk, 1987, Tamoxifen citrate therapy in male infertility, Fertil Steril, 48, 113, 10.1016/S0015-0282(16)59299-1 · DOI
- Hargreave, 1986, Randomised trial of tamoxifen versus vitamin C for male infertility, 4, 51
- Kotoulas, 1994, Tamoxifen treatment in male infertility. I.Effect on spermatozoa, Fertil Steril, 61, 911, 10.1016/S0015-0282(16)56705-3 · DOI
- Krause, 1992, Treatment of idiopathic oligozoospermia with tamoxifen - a randomized controlled study, Int J Androl, 15, 14, 10.1111/j.1365-2605.1992.tb01110.x · DOI
- Micic, 1985, Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men, J Urol, 133, 221, 10.1016/S0022-5347(17)48889-6 · DOI
- Ronnberg, 1980, The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study, Int J Androl, 3, 479, 10.1111/j.1365-2605.1980.tb00136.x · DOI · Paper page
- Carswell, 1982, Randomised trial of clomiphene citrate treatment and vitamin C for male infertility, Br J Urol, 54, 780, 10.1111/j.1464-410X.1982.tb13647.x · DOI · Paper page
- Sokol, 1988, A controlled comparison of the efficacy of clomiphene citrate in male infertility, Fertil Steril, 49, 865, 10.1016/S0015-0282(16)59898-7 · DOI
- Torok, 1985, Treatment of oligozoospermia with tamoxifen (open and controlled studies), Andrologia, 17, 497, 10.1111/j.1439-0272.1985.tb01048.x · DOI
- Wang, 1983, Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia, Fertil Steril, 40, 358, 10.1016/S0015-0282(16)47300-0 · DOI
- 1992, A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility, Int J Androl, 15, 299, 10.1111/j.1365-2605.1992.tb01129.x · DOI · Paper page
- Check, 1989, Empirical therapy of the male with clomiphene in couples with unexplained infertility, Int J Fertil, 34, 120
- Foss, 1973, The treatment of subfertile men with clomiphene citrate, J Reprod Fertil, 32, 167, 10.1530/jrf.0.0320167 · DOI
- Maier, 1988, Tamoxifen and testolactone in therapy of oligozoospermia: results of a randomized study, Eur Urol, 14, 447, 10.1159/000473006 · DOI
- Maier, 1990, Tamoxifen and kallikrein in therapy of oligoasthenozoospermia: results of a randomized study, Eur Urol, 17, 223, 10.1159/000464043 · DOI
- Paulson, 1979, Cortisone acetate versus clomiphene citrate in pre-germinal idiopathic oligospermia, J Urol, 121, 432, 10.1016/S0022-5347(17)56813-5 · doi:10.1016/s0022-5347(17)56813-5
- Semczuk, 1985, The application of Clomid in the treatment of male infertility, Materia Medica Polona, 2, 131
- Tepper, 1988, The effect of clomiphene citrate and tamoxifen on the cervical mucus, Acta Obstet Gynecol Scand, 67, 311, 10.1111/j.1600-0412.1988.tb07805.x · DOI
- Wieland, 1972, Idiopathic oligospermia: control observations and response to cisclomiphene, Fertil Steril, 23, 471, 10.1016/S0015-0282(16)39072-0 · DOI
- Willis, 1977, Hormonal effects of tamoxifen in oligospermic men, J Endocrinol, 73, 171, 10.1677/joe.0.0730171 · DOI
- Bartsch, 1981, Tamoxifen treatment in oligozoospermia, Eur Urol, 7, 283, 10.1159/000473241 · DOI
- Buvat, 1981, Treatment of 80 cases of hypospadia by tamoxifen, Isr J Med Sc, 17, 778
- Check, 1977, Improved fertility in oligospermic males treated with clomiphene citrate, Fertil Steril, 28, 746, 10.1016/S0015-0282(16)42677-4 · DOI
- Comhaire, 1976, Treatment of oligozoospermia with tamoxifen, Int J Fertil, 21, 232
- Cramer, 1979, Statistical methods in evaluating the outcome of infertility therapy, Fertil Steril, 32, 80, 10.1016/S0015-0282(16)44120-8 · DOI · Paper page
- Damber, 1989, Tamoxifen treatment of idiopathic oligozoospermia: effect on hCG-induced testicular steroidogenesis and semen variables, Scand J Urol Nephrol, 23, 241, 10.3109/00365598909180331 · DOI
- Devi, 1981, Antioestrogens, Pharmacol Ther, 12, 439, 10.1016/0163-7258(81)90091-7 · DOI
- Freund, 1966, Standards for the rating of human sperm morphology. A cooperative study, Int J Fertil, 11, 97
- Harris, 1979, Apparent effects of ascorbic acid medication on semen metal levels, Fertil Steril, 32, 455, 10.1016/S0015-0282(16)44304-9 · doi:10.1016/s0015-0282(16)44304-9
- Heller, 1969, Clomiphene citrate: a correlation of its effects on sperm concentration and morphology, total gonadotrophin and testicular cytology in normal men, J Clin Endocrinol Metab, 29, 638, 10.1210/jcem-29-5-638 · doi:10.1210/jcem-29-5-638
- Hobarth, 1990, Effect of tamoxifen and kallikrein on sperm parameters including hypoosmotic swelling test in subfertile males. A retrospective analysis, Andrologia, 22, 513, 10.1111/j.1439-0272.1990.tb02043.x · DOI
- Homonnai, 1988, Clomiphene citrate treatment in oligozoospermia: comparison between two regimens of low-dose treatment, Fertil Steril, 50, 801, 10.1016/S0015-0282(16)60319-9 · DOI
- Khan, 1996, Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as outcome measure, Fertil Steril, 65, 939, 10.1016/S0015-0282(16)58265-X · DOI
- Macleod, 1951, Male factor in fertility and infertility: spermatozoon counts in 1000 men of known fertility and in 1000 cases of infertile marriage, J Urol, 66, 436, 10.1016/S0022-5347(17)74358-3 · DOI · Paper page
- Mellinger, 1966, The effect of clomiphene citrate in male infertility, Fertil Steril, 17, 94, 10.1016/S0015-0282(16)35830-7 · DOI
- Newberne, 1966, Toxicologic studies on clomiphene, Toxicology and Applied Pharmacology, 9, 44, 10.1016/0041-008X(66)90029-9 · DOI
- Paulson, 1975, Hypofertility and clomiphene citrate therapy, Fertil Steril, 26, 982, 10.1016/S0015-0282(16)41411-1 · DOI
- Paulson, 1977, Clomiphene citrate in the management of male hypofertility: predictors for treatment selection, Fertil Steril, 28, 1226, 10.1016/S0015-0282(16)42921-3 · DOI
- Ross, 1980, Clomiphene treatment of the idiopathic hypofertile male: high dose alternative-day therapy, Fertil Steril, 33, 618, 10.1016/S0015-0282(16)44775-8 · DOI
- Schellen, 1982, Clomiphene treatment in the treatment of male infertility, 33, 10.1007/978-3-642-68223-0_3 · DOI
- Schill, 1981, Erfahrungen mit dem Antiostrogen Tamoxifen zur Therapie der Oligozoospermie, Hautarzt, 32, 306
- Smals, 1980, Tamoxifen suppresses gonadotropin-induced 16-a-hydroxy-progesterone accumulation in normal men, J Clin Endocrinol, 51, 1026, 10.1210/jcem-51-5-1026 · doi:10.1210/jcem-51-5-1026
- Traub, 1981, The effect of tamoxifen on spermatogenesis in subfertile men, Andrologia, 13, 486, 10.1111/j.1439-0272.1981.tb00087.x · DOI
- Vermeulen, 1978, Hormonal effects of an antiestrogen, Tamoxifen, in normal and oligospermic men, Fertil Steril, 29, 320, 10.1016/S0015-0282(16)43160-2 · DOI
- 1980, Laboratory manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction
Cited by
Selective estrogen receptor modulators: an update on recent clinical findings
Shelly, W., Draper, M. W., Krishnan, V., Wong, M., & Jaffe, R. B. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31816400d7 · Cited by 193
Chua, M. E., Escusa, K. G., Luna, S., Tapia, L. C., Dofitas, B., & Morales, M. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00107.x · Cited by 183
Aromatase inhibitors in men: effects and therapeutic options
de Ronde, W., & de Jong, F. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-93 · Cited by 155
Gregoriou, O., Bakas, P., Grigoriadis, C., Creatsa, M., Hassiakos, D., & Creatsas, G. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.005 · Cited by 93
Cannarella, R., Condorelli, R. A., Mongioì, L. M., Barbagallo, F., Calogero, A. E., & La Vignera, S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1615057 · Cited by 91
Metadata
- Authors
- Vandekerckhove, P., Lilford, R., Vail, A., Hughes, E., & Hafez, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 1996-10-21
- Volume
- 2010
- Issue
- 1
- Pages
- CD000151-CD000151
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2130336088
- Cited by
- 109
- References
- 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- withdrawal (1996-10-21)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. https://app.cochat.ai/papers/10.1002/14651858.cd000151
- The paper
- Vandekerckhove, P., Lilford, R., Vail, A., Hughes, E., & Hafez, M. (1996). Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000151
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.